AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
Saved in:
FUDALA, P.J., ET AL., AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE. JOURNAL OF MAINTENANCE IN THE ADDICTIONS, Vol. 1, no. 1 (1997), p. 93-101.
Ref.
104336
Location:
SIIS R.1640 Archivo
Palabras clave:
Análisis clínicos, Drogodependencias, Evaluación de servicios, Fármacos, Metadona, Opiáceos, Tratamiento médico
Análisis clínicos, Drogodependencias, Evaluación de servicios, Fármacos, Metadona, Opiáceos, Tratamiento médico
Similar Items: AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
- LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
- THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
- LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
- METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION
- LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION
- LEVO-ALPHA ACETYL METHADOL (LAAM). ITS ADVANTAGES AND DRAWBACKS